All PlansAdministrativeLow impact
Voluntary nationwide recall: Duloxetine (Towa – October)
UPMC Health Plan·Psychiatry, Neurology, Family Medicine +1 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Towa Pharmaceutical has issued a voluntary recall of Duloxetine Delayed-Release Capsules 20mg (lot 220128) due to cancer-causing impurities. This is a pharmacy-level recall that does not directly impact medical billing procedures or codes.
Action Required
Immediately: Billing team should be aware of the recall when processing claims for patients who may have been prescribed this specific lot of Duloxetine. No billing code changes are required, but staff should be prepared to assist patients who call with questions about their medication recall.